Zusammenfassung
Myasthenia gravis ist eine Autoimmunerkrankung mit schmerzloser, belastungsabhängig zunehmender Schwäche der quergestreiften Muskulatur. Eine ausführliche klinische Untersuchung ist für die präoperative Beurteilung des kardiopulmonalen und neurologischen Status betroffener Patienten unverzichtbar. Die meisten Myasthenia-gravis-Patienten sind in kontinuierlicher neurologischer Behandlung und medikamentös gut eingestellt.
Literatur
Gold R, Schneider-Gold C (2008) Current and future standards in treatment of myasthenia gravis. Neurotherapeutics 5(4):535–541
Farrugia ME, Vincent A (2010) Autoimmune mediated neuromuscular junction defects. Curr Opin Neurol 23(5):489–495
Osserman KE, Genkins G (1966) Critical reappraisal of the use of edrophonium (tensilon) chloride tests in myasthenia gravis and significance of clinical classification. Ann N Y Acad Sci 135(1):312–334
AWMF (Hrsg) (2008) Myasthenia gravis. Leitlinien für Diagnostik und Therapie in der Neurologie. Georg Thieme Verlag, Stuttgart
Osserman KE, Genkins G (1971) Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients. Mt Sinai J Med 38(6):497–537
Blobner M, Mann R (2001) Anesthesia in patients with myasthenia gravis. Anaesthesist 50(7):484–493
Dillon FX (2004) Anesthesia issues in the perioperative management of myasthenia gravis. Semin Neurol 24(1):83–94
Leventhal SR, Orkin FK, Hirsh RA (1980) Prediction of the need for postoperative mechanical ventilation in myasthenia gravis. Anesthesiology 53(1):26–30
Blichfeldt-Lauridsen L, Hansen BD (2012) Anesthesia and myasthenia gravis. Acta Anaesthesiol Scand 56(1):17–22
Mekis D, Kamenik M (2005) Remifentanil and high thoracic epidural anaesthesia: a successful combination for patients with myasthenia gravis undergoing transsternal thymectomy. Eur J Anaesthesiol 22(5):397–399
Mencke T, Echternach M, Kleinschmidt S, Lux P, Barth V, Plinkert PK, Fuchs-Buder T (2003) Laryngeal morbidity and quality of tracheal intubation: a randomized controlled trial. Anesthesiology 98(5):1049–1056
Mann R, Blobner M, Jelen-Esselborn S, Busley R, Werner C (2000) Preanesthetic train-of-four fade predicts the atracurium requirement of myasthenia gravis patients. Anesthesiology 93(2):346–350
Unterbuchner C, Fink H, Blobner M (2010) The use of sugammadex in a patient with myasthenia gravis. Anaesthesia 65(3):302–305
de Boer HD, Shields MO, Booij LH (2014) Reversal of neuromuscular blockade with sugammadex in patients with myasthenia gravis: a case series of 21 patients and review of the literature. Eur J Anaesthesiol 31(12):715–721
Eisenkraft JB, Book WJ, Mann SM, Papatestas AE, Hubbard M (1988) Resistance to succinylcholine in myasthenia gravis: a dose-response study. Anesthesiology 69(5):760–763
Nitahara K, Sugi Y, Higa K, Shono S, Hamada T (2007) Neuromuscular effects of sevoflurane in myasthenia gravis patients. Br J Anaesth 98(3):337–341
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2016 © Springer-Verlag GmbH Deutschland
About this entry
Cite this entry
Lewald, H., Blobner, M. (2016). Anästhesie bei Patienten mit Myasthenia gravis. In: Rossaint, R., Werner, C., Zwißler, B. (eds) Die Anästhesiologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45539-5_113-1
Download citation
DOI: https://doi.org/10.1007/978-3-662-45539-5_113-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-45539-5
Online ISBN: 978-3-662-45539-5
eBook Packages: Springer Referenz Medizin